References
- Ruggery Z M. Von Willebrand factor, platelets and endothelial cell interactions. J Thromb Haemost 2003; 1: 1335–42.
- Berndt M C, Shen Y, Dopheide S M, Gardiner E E, Andrews R K. The vascular biology of the glycoprotein Ib-IX-V complex. Thromb Haemost 2001; 86: 178–88.
- De Marko L, Girolami A, Zimmerman T S, Ruggeri Z M. Von Willebrand factor interaction with the glycoprotein IIb/ IIIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia. J Clin Invest 1986; 77: 1272–7.
- Harfenist E J, Packham M A, Kinlough-Rathbone R L, Cattaneo M, Mustard J F. Effect of calcium ion concentration on the ability of fibrinogen and von Willebrand factor to support the ADP-induced aggregation of human platelets. Blood 1987; 70: 827–31.
- Goto S, Ikeda Y, Saldivar E, Ruggeri Z M. Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions. J Clin Invest 1998; 101: 479–86.
- Berndt M C, Du X, Booth W J. Ristocitin-dependent reconstitution of binding of von Willebrand factor to purified human platelet membrane glycoprotein Ib-IX complex. Biochemistry 1988; 27: 633–40.
- Byzova T V, Vlasik T N, Mazurov A V. Inhibition of platelet aggregation by monoclonal antibodies to glycoprotein complex IIb–IIIa. Biull Eksp Biol Med 1994; 118: 402–5 (in Russian).
- Mazurov A V, Pevzner D V, Khaspekova S G, Dudnik O A, Byzova T V, Vlasik T N, Bakharev V N, Piscov M Yu, Staroverov I I, Ruda M Ya. Inhibition of platelet aggregation by F(ab0)2 fragments of monoclonal antibody FRaMon (CRC64) against glycoproteins IIb–IIIa in vitro and in healthy volunteers. Ter Arkh 2001, 73: 66–73 (in Russian).
- Mazurov A V, Khaspekova S G, Byzova T V, Tikhomirov O Yu, Berndt M C, Steiner B, Kouns W C. Stimulation of platelet glycoprotein IIb–IIIa (aIIbb3-integrin) functional activity by a monoclonal antibody to the N-terminal region of glycoprotein IIIa. FEBS Lett 1996; 391: 84–8.
- Naimushin YaA, Mazurov A V. Role of glycoprotein IIb–IIIa (aIIbb3-integrin) in the stimulation of secretion from platelet granules. Biochemistry (Moscow) 2003; 68: 209–16.
- Khaspekova S G, Vlasik T N, Byzova T V, Vinogradov D V, Berndt M C, Mazurov A V. Detection of the epitope specific for the dissociated form of glycoprotein IIIa of platelet membrane glycoprotein IIb–IIIa complex and its expression on the surface of adherent platelets. Br J Haematology 1993; 85: 332–40.
- Mazurov A V, Vinogradov D V, Kabaeva N V, Antonova G N, Romanov YuA, Vlasik T N, Antonov A S, Smirnov V N. A monoclonal antibody, VM64, reacts with a 130 kDa glyco- protein common to platelets and endothelial cells: hetero- geneity in antibody binding to human aortic endothelial cells. Thromb Haemost 1991; 66: 494–9.
- Smirnova I V, Khaspekova S G, Ignatov V V, Mazurov A V. Interaction of wheat germ agglutinin and concanavalin A with platelets. Stimulation of platelet functional reactions and bind- ing with membrane glycoproteins. Biochemistry (Moscow) 1998; 63: 710–18.
- Agafonova O G, Vinogradov D V, Khaspekova S G, Lagutina N Ya, Labinskaya T A, Vasil’ev S A, Mazurov A V. The immunodiagnosis of thrombocyte membrane glycoprotein deficiencies: Glanzmann’s thrombasthenia, Bernard–Soulier syndrome and GMP-140 deficiency. Biull Eksp Biol Med 1992; 114: 635–7 (in Russian).
- Suzuki K, Sato K, Kamohara M, Kaku S, Kawasaki T, Yano S, Iizumi Y. Comparative studies of a humanized anti- glycoprotein IIb–IIIa monoclonal antibody, YM 337, and abciximab on in vitro antiplatelet effect and binding properties. Biol Pharm Bull 2002; 25: 1006–12.
- Frelinder A L, Du X, Plow E F, Ginsberg M H. Monoclonal antibodies to ligand-induced conformers of integrin aIIbb3 (glycoprotein IIb–IIIa) alter receptor affinity, specificity and function. J Biol Chem 1991; 266: 17106–11.
- Kouns W C, Wall C D, White M M, Fox C F, Jennings L K. A conformation dependent epitope of human platelet glyco- protein IIIa. J Biol Chem 1990; 265: 20594–601.
- Mondoro T H, Wall C D, White M M, Jennings L K. Selective inhibition of a glycoprotein IIIa ligand-induced binding site by fibrinogen and von Willebrand factor. Blood 1996; 88: 3824–30.
- Lages B, Weiss H J. Dependence of human platelet functional responses on divalent cations: aggregation and secretion in heparin- and hirudin-anticoagulated platelet-rich plasma and the effects of chelating agents. Thromb Haemost 1981; 45: 173–9.